Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChemring Regulatory News (CHG)

Share Price Information for Chemring (CHG)

Share Price is delayed by 15 minutes
Get Live Data
512.00    25.00 (5.13%)
Bid:
514.00
Ask:
515.00
Spread: 1.00 (0.195%)
Market Cap: £1.39b
CHG Live PriceLast checked at - London Stock Exchange

Intraday Chemring Share Chart

Director/PDMR Shareholding

16 Dec 2025 07:00

RNS Number : 6645L
Chemring Group PLC
16 December 2025
 

16 December 2025

 

Chemring Group PLC

 

PDMR share dealings

 

 

Chemring Group PLC ("Chemring" or "the Company") announces that, on 15 December 2025, an award of 42,838 deferred ordinary 1p shares in the capital of the Company previously granted to Sarah Ellard, a director of the Company, vested. The deferred share award was originally made in satisfaction of 40% of Mrs Ellard's annual bonus payment for the year ended 31 October 2022. 42,838 ordinary 1p shares were subsequently sold, of which 20,134 shares were sold by the Company on behalf of Mrs Ellard to cover tax and national insurance liabilities arising on vesting.

 

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

 

 Sarah Ellard

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Director/PDMR

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Chemring Group PLC

b)

 

LEI

 

 

213800U9A54VQJ5P2J41

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Deferred award over ordinary 1p shares

 

 

 

GB00B45C9X44

b)

 

Nature of the transaction

 

 

Vesting of deferred award of shares in partial satisfaction of an annual bonus payment

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

 

Nil

 

42,838

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

 

 

 

 

 

 

 

e)

 

Date of the transaction

 

 

15 December 2025

f)

 

Place of the transaction

 

 

Outside a trading venue

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

 

 Sarah Ellard

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Director/PDMR

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Chemring Group PLC

b)

 

LEI

 

 

213800U9A54VQJ5P2J41

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary 1p shares

 

 

 

GB00B45C9X44

b)

 

Nature of the transaction

 

 

Sale of ordinary 1p shares following vesting of deferred share award

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

 

481p

 

42,838

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

 

 

 

 

 

 

e)

 

Date of the transaction

 

 

15 December 2025

f)

 

Place of the transaction

 

 

XLON - London Stock Exchange

 

 

For further information:

 

Chemring Group PLC

Sarah Ellard

Group Legal Director

+44 (0)7710 553757

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFFFIFFTLELIE
Date   Source Headline
8th Aug 20187:12 amRNSDirectorate Change
6th Aug 20182:16 pmRNSHolding(s) in Company
1st Aug 20189:32 amRNSTotal Voting Rights
30th Jul 20181:24 pmRNSDirector/PDMR Shareholding
2nd Jul 201810:44 amRNSTotal Voting Rights
2nd Jul 20187:00 amRNSCONTRACT AWARDS
26th Jun 20183:54 pmRNSDirector/PDMR Shareholding
22nd Jun 20182:40 pmRNSBlock listing Interim Review
22nd Jun 20182:39 pmRNSBlock listing Interim Review
21st Jun 20187:00 amRNSINTERIM RESULTS
8th Jun 20181:37 pmRNSAdditional Listing
4th Jun 20187:00 amRNSTotal Voting Rights
24th May 20187:00 amRNSCONTRACT AWARDS
1st May 201810:26 amRNSTotal Voting Rights
1st May 20187:00 amRNSDirectorate Change
27th Apr 20183:41 pmRNSHolding(s) in Company
23rd Apr 201811:55 amRNSHolding(s) in Company
19th Apr 20187:00 amRNSContract Award
3rd Apr 20181:03 pmRNSTotal Voting Rights
23rd Mar 20187:00 amRNSChange of auditor
20th Mar 20182:17 pmRNSResult of AGM
20th Mar 20187:00 amRNSAGM Statement
1st Mar 201811:02 amRNSTotal Voting Rights
23rd Feb 201810:35 amRNSHolding(s) in Company
15th Feb 201810:23 amRNSNotice of AGM
8th Feb 20184:27 pmRNSHolding(s) in Company
5th Feb 201812:10 pmRNSHolding(s) in Company
1st Feb 201810:51 amRNSTotal Voting Rights
1st Feb 20187:00 amRNSContract Award
29th Jan 20185:38 pmRNSHolding(s) in Company
29th Jan 20182:30 pmRNSDirector/PDMR Shareholding
29th Jan 20182:28 pmRNSDirector/PDMR Shareholding
29th Jan 20182:25 pmRNSDirector/PDMR Shareholding
29th Jan 20182:25 pmRNSDirector/PDMR Shareholding
29th Jan 20181:47 pmRNSDirector/PDMR Shareholding
29th Jan 20181:43 pmRNSDirector/PDMR Shareholding
29th Jan 20181:38 pmRNSDirector/PDMR Shareholding
29th Jan 20181:38 pmRNSDirector/PDMR Shareholding
29th Jan 201810:46 amRNSTransaction in Own Shares
29th Jan 201810:23 amRNSTransaction in Own Shares
26th Jan 201812:32 pmRNSHolding(s) in Company
26th Jan 201812:26 pmRNSHolding(s) in Company
23rd Jan 201810:41 amRNSHolding(s) in Company
22nd Jan 201810:11 amRNSDirector/PDMR Shareholding
22nd Jan 201810:08 amRNSDirector/PDMR Shareholding
22nd Jan 201810:03 amRNSDirector/PDMR Shareholding
22nd Jan 201810:02 amRNSDirector/PDMR Shareholding
22nd Jan 201810:00 amRNSDirector/PDMR Shareholding
22nd Jan 201810:00 amRNSDirector/PDMR Shareholding
18th Jan 20187:00 amRNSFULL YEAR RESULTS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.